FDA Import Refusal AEK-9592351-0/10002/1B — AbbVie Inc.
The FDA refused shipment AEK-9592351-0/10002/1B from AbbVie Inc. (United States) on Sep 28, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 28, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 58PCZ05 ONABOTULINUMTOXINA
- Charges
- 75